Papilloedema Tidak Spesifik (H47.1): Definisi, Penyebab, Diagnosis, dan Tatalaksana

1. Miller NR, Newman NJ, Biousse V, Kerrison JB. Walsh & Hoyt's Clinical Neuro-Ophthalmology: The Essentials. 3rd ed. Philadelphia: Wolters Kluwer; 2020.

2. Lee AG, Brazis PW. Clinical Pathways in Neuro-Ophthalmology: An Evidence-Based Approach. 3rd ed. New York: Thieme Medical Publishers; 2018.

3. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165.

4. Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693-701.

5. Passi N, Degnan AJ, Levy LM. MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and intracranial space-occupying lesions. Neuroimaging Clin N Am. 2013;23(4):629-640.

6. Frisén L. Swelling of the optic nerve head: a staging in papilledema. Ophthalmologica. 1982;184(2):85-91.

7. Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83(5):488-494.

8. Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Headache. 2014;54(2):389-393.

9. Mollan SP, Ali F, Hassan-Smith G, et al. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):971-982.

10. Digre KB, Bruce BB, McDermott MP, et al. Quality of life in idiopathic intracranial hypertension. Am J Ophthalmol. 2015;160(1):192-197.